UT Southwestern cardiologist receives NIH Outstanding Investigator Award

UT Southwestern physician-scientist Hesham Sadek, M.D., Ph.D., has received the prestigious National Institutes of Health (NIH) Outstanding Investigator Award to support his ongoing research into mechanisms behind heart regeneration that could lead to treatments for heart failure.

This Groundbreaking Biomaterial Heals Tissues From the Inside Out

A new biomaterial that can be injected intravenously, reduces inflammation in tissue and promotes cell and tissue repair. The biomaterial was tested and proven effective in treating tissue damage caused by heart attacks in both rodent and large animal models. Researchers also provided proof of concept in a rodent model that the biomaterial could be beneficial to patients with traumatic brain injury and pulmonary arterial hypertension.

Study finds how our brains turn into smarter disease fighters

Irvine, Calif., Jan. 30, 2023 — Combating Alzheimer’s and other neurodegenerative diseases by inserting healthy new immune cells into the brain has taken a leap toward reality. Neuroscientists at the University of California, Irvine and the University of Pennsylvania have found a way to safely thwart the brain’s resistance to them, vaulting a key hurdle in the quest.

What is MINOCA? A Type of Heart Attack Mostly Affecting Women

Heart disease is the leading cause of death among women in the U.S., and a type of heart attack called myocardial infarction with non-obstructive coronary arteries (MINOCA), which predominantly affects women, is garnering increased attention.

Moffitt Cancer Center Joins Weill Cornell Medicine and University of North Carolina to Improve HIV-Related Cancer Care Abroad

Moffitt Cancer Center, Weill Cornell Medicine and the University of North Carolina School of Medicine have received a $3.5 million, five-year grant from the National Cancer Institute (NCI) to improve screening and preventative treatment of cervical cancer for women living with HIV in low-resource countries.

Cancer Survivors may be at Risk for Heart Disease

The bottom line: before, during and after cancer treatment, heart health is critical. Andrew M. Evens, DO, MBA, MSc, associate director for Clinical Services at Rutgers Cancer Institute of New Jersey and medical director of the Oncology Service Line at RWJBarnabas Health, is a participating physician in the Cardio-Oncology Program at Rutgers Cancer Institute of New Jersey, the state’s leading cancer program, in partnership with RWJBarnabas Health, shares more on the topic.

Cancer Prevention Experts Provide Top Tips for Reducing Cancer Risk

Elisa V. Bandera, MD, PhD and Carolyn J. Heckman, PhD, co-leaders of the Cancer Prevention and Control Research Program at Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute (NCI)-Designated Comprehensive Cancer Center, together with RWJBarnabas Health, share their top tips for cancer prevention during National Cancer Prevention Month.

Mount Sinai Researchers Identify Functions of Muscle Surrounding Hair Follicles That Cause Hair Regression

MEDIA ADVISORY UNDER EMBARGO UNTIL 11:00AM ET, MONDAY, JANUARY 30, 2023 Paper Title: Progenitor-derived endothelin controls dermal sheath contraction for hair follicle regression Journal: Nature Cell Biology (January 30, 2023) Authors: Michael Rendl, MD, Professor of Cell, Developmental and Regenerative Biology,…

Call for Nominations – Acoustical Society of America Science Communication Awards

The Acoustical Society of America offers Science Communication Awards in Acoustics to recognize excellence in the communication of acoustics-related topics to a popular audience. The 2023 award cycle will accept content created between Jan. 1, 2021, and Dec. 31, 2022; if you have seen, heard, or created something acoustics-related during this time frame, please nominate it! Each nominated entry will be judged according to its general accessibility, relevance to acoustics, accuracy, and quality. Nominations will be accepted until March 15, 2023.

Mount Sinai Launches Center to Address Bias and Racism Against Asian Americans and Pacific Islanders

Seeking to address racism and bias against
Asian Americans and Pacific Islanders (AAPI), as well as the under-representation of AAPI in leadership roles in medicine, Mount Sinai announced today the launch of the Center for Asian Equity and Professional Development (CAEPD). This innovative undertaking represents one of the first of its kind nationwide by an academic medical center.

Hackensack Meridian JFK University Medical Center Offers Innovative PSMA PET Imaging Test to Aid in Diagnosis of Prostate Cancer

“The availability of the PYLARIFY test at JFK University Medical Center means patients with prostate cancer no longer need to travel to obtain PSMA-targeted PET imaging. They can get this innovative technology close to home,” said Amie Thornton, president, chief hospital executive, JFK University Medical Center.

New Study Finds Depression, Poor Mental Health Linked to Higher Heart Disease Risks Among Young Adults

Young adults who feel down or depressed are more likely to develop cardiovascular disease (CVD) and have poor heart health, according to a new study led by Johns Hopkins Medicine researchers who analyzed data from more than a half million people between the ages of 18 and 49. The findings add to a growing body of evidence connecting CVD with depression among young and middle-aged adults and suggest the relationship between the two could begin in early adulthood.

RUDN University professors showed how to predict the destruction of components up to 4 times more accurately

Current engineering science cannot accurately predict when an industrial component will fail under cyclic loads. The collaboration research carried out by the professor of the Department of Transport and the Associate Professor of the Department of Engineering Technologies of RUDN University proposed a new approach for calculation and showed that it is 1.5-4 times more accurate than the classical one.

Study Unravels Interplay Between Sleep, Chronic Pain and Spinal Cord Stimulation

Spinal cord stimulation uses low levels of electricity to relieve pain. A study is the first to measure this treatment’s effects on patients by gauging improvement in insomnia after spinal cord stimulation. Results showed a 30 percent or more improvement of both nighttime and daytime components of insomnia in 39.1 percent of study participants and a 30 percent or more improvement of daytime sleepiness in 28.1 percent of participants. Findings correlated with improvement in disability and depression and revealed associations with sleep and both pain and depression. Results will help clinicians gain a better understanding of the type of patient most likely to benefit from this treatment.

NUS researchers revisit potent drug as promising treatment for acute leukaemia

A team of researchers from the Cancer Science Institute of Singapore at the National University of Singapore has breathed new life into an existing drug — combatting a type of blood cancer called T-cell acute lymphoblastic leukaemia, or T-ALL. The drug, called PIK-75, was initially discovered over a decade ago but was dismissed in favour of newer ones. Now, it has made a comeback that deems it unmissable — the researchers established that the drug could block not just one but two crucial cancer-causing pathways of T-ALL, enabling them to develop new treatments that could effectively stem the disease.

DePaul University experts available to discuss upcoming Chicago elections

As Chicago voters head to the polls in less than a month to decide the next mayor of the third largest city in the U.S.—in addition to aldermanic elections in all 50 city wards—DePaul University faculty experts are available to provide insight and commentary.

Results of the SORAYA study show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

In an internationally conducted clinical trial lead by Dana-Farber involving patients with recurrent ovarian cancer that is resistant to platinum therapy, a novel conjugate therapy called mirvetuximab soravtansine resulted in substantially better responses than standard treatments. Mirvetuximab soravtansine was granted accelerated approval by the U.S. Food and Drug Administration (FDA) in November 2022.

Study: Obstructive sleep apnea tied to weaker bones and teeth in adults

Obstructive sleep apnea may be linked to low bone mineral density in adults, according to University at Buffalo-led research. The findings are crucial for individuals with sleep apnea, as low bone mineral density is an indicator of osteoporosis – a condition in which bones become weak and brittle.

Is brain learning weaker than artificial Intelligence?

Can the brain, with its limited realization of precise mathematical operations, compete with advanced artificial intelligence systems implemented on fast and parallel computers? From our daily experience we know that for many tasks the answer is yes! Why is this and, given this affirmative answer, can one build a new type of efficient artificial intelligence inspired by the brain? In an article published today in Scientific Reports, researchers from Bar-Ilan University in Israel solve this puzzle.

Targeted therapy momelotinib provides significant symptom and anemia improvements in patients with myelofibrosis

Patients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anemia and spleen enlargement, when treated with the targeted therapy momelotinib, according to results from the international Phase III MOMENTUM trial led by researchers at The University of Texas MD Anderson Cancer Center.

Chulalongkorn Business School in Collaboration with the Faculty of Medicine Siriraj Hospital, Mahidol University, for Excellence in Academics and Management

On Monday, January 9, 2023, at Meeting Room 2, 2nd Floor, Jaiyossompati Building 2, the Faculty of Commerce and Accountancy, Chulalongkorn University Assoc. Prof. Dr. Wilert Puriwat, Dean of Chulalongkorn Business School, and Prof. Dr. Apichat Asavamongkolkul, Dean of the Faculty of Medicine Siriraj Hospital, Mahidol University, signed an agreement for an academic collaboration between Chulalongkorn Business School and the Faculty of Medicine Siriraj Hospital, Mahidol University, to enhance excellence in academics and management.